Specialties: US Generics , Plumonary devices , Alliance Managment , Project Managment

General Manager , Product Strategy & Business Planning @ From July 2014 to Present (1 year 6 months) Deputy General Manager, Product Strategy (Respiratory) @ From July 2012 to June 2014 (2 years) Senior Manager - Corporate Strategy @ In Licensing , Alliance Management , Global M&A activities , Project Management of high value and critical projects , Business Planning. From September 2010 to June 2012 (1 year 10 months) Mumbai Area, IndiaSr Manager Strategic Planning @ New Product Launches & Long Term Capacity Planning , Business Planning and Risk Mitigation , Business Development support. From November 2008 to August 2010 (1 year 10 months) Mumbai Area, IndiaManager , Intellectual Property Managment Group @ Key Areas included in the scenario includes the following. • Product Identification: - Responsible for screening of molecules across various therapeutic segments and markets based on market scenario, sales, patent and medical coverage. Author, a detailed business plan covering all aspects from sales, patent details and strategies and tentative launch dates to yearly sales revenue breakup and finally backed up with financial modeling for individual project. •Therapeutic category Identification: Spearheaded the project for identifying therapeutic categories of business interest based on competitive analysis, manufacturing feasibility, regulatory environment and future market trends. •Competitive Intelligence: Developed numerous competitive intelligence reports to appraise the top management on the competitors & innovators profile to gain first movers advantage covering financial models, making marketing and other launch decisions. •Business Model Development: Responsible for developing financial models for all pipeline molecules and molecules of future interest. Report includes granular trend analysis of the innovator brand sales. This activity is primarily done to calculate NPV, IRR of projects to serve as basis for project selection and estimating ROI. •Company mapping: Responsible for reviewing company profile, product baskets for business opportunities. This activity is undertaken for mapping competition into niche areas where we intend to enter. The report involves granular market analysis, financial analysis of competitor companies to evaluate strengths and their competitive advantage in market. Also this activity is done for evaluating potential targets for M & A or other licensing activities. •Support to M& A – Responsible for business analysis and business appreciation for potential M& A companies. This would involve evaluation of the company, its product range and see if this fits in our company strategy. From May 2005 to October 2008 (3 years 6 months)

MBA, Pharmaceutical Marketing @ Narsee Monjee Institute of Management Studies From 2003 to 2005 Bachelor of Pharmacuticals @ C U Shah College of Pharmacy From 1999 to 2003 Poonam Shenoy is skilled in: Project Management, Pharmaceutics, Competitive Intelligence, Technology Transfer, Competitive Analysis, Project Planning, Generic Drugs, Business Intelligence, Business Strategy, Dry Powder Inhalers, Cross-functional Team Leadership, Strategic Planning, Pharmaceutical Industry, Regulatory Affairs, ANDA